Skip to main content

Oncology Expert Insights

First Report Managed Care
By Edan Stanley Gary Owens, MD, president of Gary Owens Associates, shares a payer perspective on treatment options for chronic lymphocytic leukemia, and weighs the benefits and challenges of using targeted therapy with ibrutinib compared with traditional chemoimmunotherapy. Please introduce…
Back to Top